Index -
P/E -
EPS (ttm) -0.45
Insider Own 1.09%
Shs Outstand 207.20M
Perf Week 1.40%
Market Cap 5.87B
Forward P/E 11.97
EPS next Y 2.36
Insider Trans 1.34%
Shs Float 205.37M
Perf Month -7.10%
Income -95.00M
PEG -
EPS next Q 0.50
Inst Own 103.23%
Short Float 5.35%
Perf Quarter -15.78%
Sales 3.94B
P/S 1.49
EPS this Y 10.53%
Inst Trans 1.72%
Short Ratio 3.15
Perf Half Y -3.55%
Book/sh 15.69
P/B 1.80
EPS next Y 16.76%
ROA -1.28%
Short Interest 10.99M
Perf Year -29.55%
Cash/sh 1.40
P/C 20.18
EPS next 5Y 12.50%
ROE -2.75%
52W Range 26.27 - 41.65
Perf YTD -20.54%
Dividend Est. 0.89 (3.16%)
P/FCF 21.05
EPS past 5Y 32.70%
ROI -1.85%
52W High -32.09%
Beta 1.04
Dividend TTM 0.58 (2.05%)
Quick Ratio 0.97
Sales past 5Y 0.88%
Gross Margin 52.69%
52W Low 7.65%
ATR (14) 0.69
Dividend Ex-Date Mar 27, 2024
Current Ratio 1.43
EPS Y/Y TTM 90.80%
Oper. Margin 7.36%
RSI (14) 33.92
Volatility 2.08% 2.18%
Employees 15000
Debt/Eq 0.68
Sales Y/Y TTM 0.23%
Profit Margin -2.41%
Recom 2.00
Target Price 34.54
Option/Short Yes / Yes
LT Debt/Eq 0.57
EPS Q/Q 197.40%
Payout -
Rel Volume 0.63
Prev Close 28.38
Sales Surprise -1.70%
EPS Surprise 0.67%
Sales Q/Q -2.56%
Earnings May 02 BMO
Avg Volume 3.49M
Price 28.28
SMA20 -3.23%
SMA50 -9.35%
SMA200 -15.06%
Trades
Volume 2,196,809
Change -0.35%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Outperform
$42
Nov-16-23 Initiated
Needham
Buy
$35
Nov-10-23 Upgrade
William Blair
Mkt Perform → Outperform
Jan-12-23 Upgrade
William Blair
Underperform → Mkt Perform
Aug-05-22 Downgrade
William Blair
Mkt Perform → Underperform
Jun-02-22 Upgrade
UBS
Neutral → Buy
$58 → $47
Apr-20-22 Downgrade
William Blair
Outperform → Mkt Perform
Apr-20-22 Downgrade
Piper Sandler
Overweight → Neutral
$46
Apr-19-22 Downgrade
Robert W. Baird
Outperform → Neutral
$67 → $48
Apr-19-22 Downgrade
BofA Securities
Buy → Neutral
$66 → $49
Jan-31-22 Initiated
Morgan Stanley
Overweight
$62
Oct-01-21 Resumed
Credit Suisse
Outperform
$74
Aug-09-21 Reiterated
H.C. Wainwright
Neutral
$72 → $66
Aug-06-21 Reiterated
Barrington Research
Outperform
$77 → $79
Aug-05-21 Resumed
Credit Suisse
Outperform
$74
Mar-02-21 Upgrade
Barrington Research
Mkt Perform → Outperform
$71
Mar-02-21 Reiterated
H.C. Wainwright
Neutral
$55 → $60
Jan-05-21 Reiterated
H.C. Wainwright
Neutral
$49 → $55
Dec-18-20 Downgrade
Stifel
Buy → Hold
$52
Nov-17-20 Downgrade
Barclays
Equal Weight → Underweight
$40
Show Previous Ratings
May-08-24 04:15PM
May-06-24 09:25AM
May-03-24 12:30PM
11:54AM
10:24AM
09:43AM
Loading…
09:43AM
08:41AM
03:09AM
May-02-24 08:57PM
(Morningstar Research) -5.96%
01:05PM
11:30AM
10:55AM
10:18AM
08:36AM
07:10AM
06:06AM
Loading…
06:06AM
(Associated Press Finance)
06:00AM
Apr-30-24 12:22PM
Apr-22-24 09:40AM
Apr-09-24 04:30PM
Apr-04-24 09:40AM
Apr-02-24 09:45AM
07:31AM
Apr-01-24 01:26PM
Mar-30-24 05:17PM
Mar-27-24 06:38PM
06:12PM
Mar-21-24 10:42AM
Mar-19-24 09:40AM
Mar-01-24 09:52AM
08:23PM
Loading…
Feb-29-24 08:23PM
09:30AM
08:46AM
07:51AM
07:46AM
07:10AM
06:30AM
06:17AM
(Associated Press Finance)
06:00AM
Feb-26-24 11:37AM
09:16AM
Feb-07-24 12:10PM
Jan-29-24 04:15PM
Jan-23-24 08:57AM
Jan-18-24 10:00AM
Jan-17-24 07:33PM
Jan-10-24 07:32PM
Jan-09-24 08:30AM
Jan-03-24 08:00AM
Dec-22-23 10:00AM
Dec-21-23 07:58AM
Nov-22-23 11:43AM
Nov-21-23 07:39PM
03:51PM
01:04PM
Nov-16-23 08:30AM
Nov-10-23 03:30PM
Nov-09-23 08:00AM
Nov-03-23 11:01AM
Nov-02-23 07:45PM
(Morningstar Research) -7.46%
10:54AM
09:30AM
09:27AM
07:30AM
06:17AM
(Associated Press Finance)
06:00AM
Nov-01-23 12:10PM
07:46AM
Oct-30-23 08:19AM
Oct-27-23 10:00AM
Oct-26-23 10:02AM
Oct-25-23 05:20AM
Oct-23-23 08:00AM
Oct-19-23 12:17PM
Oct-18-23 08:00AM
Sep-29-23 08:00AM
Sep-25-23 01:00PM
Sep-21-23 06:00AM
Sep-19-23 11:10AM
Aug-18-23 10:30AM
Aug-05-23 12:48PM
Aug-03-23 11:48PM
(Thomson Reuters StreetEvents)
10:53AM
Aug-02-23 06:36PM
04:30PM
Aug-01-23 09:11AM
Jul-25-23 11:46AM
Jul-24-23 08:59AM
Jul-21-23 09:15AM
Jul-19-23 07:24AM
Jul-17-23 07:05AM
Jul-12-23 12:00PM
Jul-09-23 04:04AM
Jun-27-23 11:38AM
Jun-23-23 08:49AM
Jun-21-23 08:00PM
Jun-15-23 07:28AM
Jun-11-23 09:08AM
Jun-02-23 11:35AM
May-26-23 09:55AM
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LUCIER GREGORY T Director Nov 22 '23 Buy 31.44 10,000 314,400 43,121 Nov 27 04:34 PM Coleman Glenn Executive VP & CFO Nov 20 '23 Buy 29.70 10,000 297,000 73,566 Nov 20 04:10 PM Campion Simon D President, CEO & Member of BOD Nov 20 '23 Buy 29.70 10,000 297,000 243,930 Nov 20 04:08 PM
Index -
P/E -
EPS (ttm) -0.42
Insider Own 0.01%
Shs Outstand 1.12B
Perf Week 0.25%
Market Cap 18.26B
Forward P/E 6.02
EPS next Y 2.70
Insider Trans -86.54%
Shs Float 1.12B
Perf Month 27.46%
Income -461.00M
PEG -
EPS next Q 0.60
Inst Own 53.51%
Short Float 1.09%
Perf Quarter 25.12%
Sales 16.02B
P/S 1.14
EPS this Y -4.95%
Inst Trans 8.96%
Short Ratio 1.20
Perf Half Y 81.81%
Book/sh 6.43
P/B 2.54
EPS next Y 11.13%
ROA -1.07%
Short Interest 12.22M
Perf Year 100.37%
Cash/sh 2.67
P/C 6.11
EPS next 5Y 1.60%
ROE -6.08%
52W Range 7.09 - 17.13
Perf YTD 56.03%
Dividend Est. -
P/FCF 7.85
EPS past 5Y 26.63%
ROI -1.91%
52W High -4.90%
Beta 0.90
Dividend TTM -
Quick Ratio 0.61
Sales past 5Y -2.68%
Gross Margin 49.00%
52W Low 129.92%
ATR (14) 0.51
Dividend Ex-Date Nov 27, 2017
Current Ratio 0.89
EPS Y/Y TTM 71.44%
Oper. Margin 20.90%
RSI (14) 68.77
Volatility 3.07% 3.28%
Employees 37226
Debt/Eq 2.74
Sales Y/Y TTM 7.21%
Profit Margin -2.88%
Recom 2.08
Target Price 18.00
Option/Short Yes / Yes
LT Debt/Eq 2.32
EPS Q/Q 32.68%
Payout -
Rel Volume 0.75
Prev Close 16.30
Sales Surprise 2.34%
EPS Surprise -6.58%
Sales Q/Q 4.84%
Earnings May 08 BMO
Avg Volume 10.19M
Price 16.29
SMA20 11.55%
SMA50 15.88%
SMA200 44.46%
Trades
Volume 7,610,316
Change -0.06%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-08-24 Upgrade
JP Morgan
Underweight → Neutral
$14
Feb-12-24 Upgrade
Piper Sandler
Neutral → Overweight
$12 → $19
Jan-23-24 Upgrade
Jefferies
Hold → Buy
$10 → $14
Jan-03-24 Upgrade
Piper Sandler
Underweight → Neutral
$8 → $12
Dec-18-23 Initiated
HSBC Securities
Buy
$13
Nov-27-23 Upgrade
UBS
Neutral → Buy
$11 → $13
Jul-06-23 Upgrade
UBS
Sell → Neutral
$7 → $8
May-25-23 Initiated
Morgan Stanley
Equal-Weight
$10
May-18-23 Upgrade
Evercore ISI
In-line → Outperform
Jan-19-23 Downgrade
Jefferies
Buy → Hold
$10 → $12
Nov-14-22 Downgrade
JP Morgan
Neutral → Underweight
$11 → $10
Nov-04-22 Downgrade
UBS
Neutral → Sell
Oct-21-22 Resumed
Jefferies
Buy
$10
Aug-05-22 Upgrade
BofA Securities
Neutral → Buy
$10 → $13
Jun-14-22 Resumed
UBS
Neutral
$10
May-17-22 Upgrade
BofA Securities
Underperform → Neutral
$9
May-04-22 Downgrade
Piper Sandler
Neutral → Underweight
$11 → $7
Apr-05-22 Upgrade
Barclays
Equal Weight → Overweight
$11 → $13
Mar-25-22 Upgrade
Bernstein
Mkt Perform → Outperform
$11
Jan-27-22 Downgrade
Argus
Buy → Hold
Show Previous Ratings
May-17-24 11:00AM
09:06AM
May-16-24 06:15AM
May-15-24 09:12AM
08:15AM
07:00AM
Loading…
May-14-24 07:00AM
(The Wall Street Journal)
May-13-24 09:40AM
09:40AM
May-09-24 11:37AM
09:33AM
06:22AM
May-08-24 04:29PM
(Morningstar Research) +12.83%
04:02PM
(Investor's Business Daily)
02:10PM
02:00PM
12:51PM
Loading…
12:51PM
11:56AM
10:47AM
(Investor's Business Daily)
09:42AM
09:30AM
09:18AM
08:53AM
08:53AM
(Investor's Business Daily)
07:58AM
07:55AM
07:28AM
07:20AM
07:19AM
07:00AM
06:56AM
06:36AM
Loading…
06:36AM
06:30AM
May-07-24 04:30PM
12:45PM
May-03-24 05:58PM
(Investor's Business Daily)
09:15AM
May-02-24 06:30PM
10:48AM
08:30AM
08:01AM
(Thomson Reuters StreetEvents)
03:41AM
Apr-30-24 11:32AM
04:00AM
Apr-22-24 11:37AM
Apr-21-24 10:39AM
Apr-16-24 05:43PM
08:00AM
Apr-15-24 05:21PM
Apr-11-24 08:30AM
Apr-09-24 04:30PM
Apr-06-24 01:00PM
Apr-04-24 08:30AM
Apr-03-24 05:21AM
05:00AM
Apr-01-24 02:01PM
11:52AM
08:30AM
Mar-24-24 07:30PM
Mar-21-24 11:10PM
(Thomson Reuters StreetEvents)
Mar-18-24 03:06PM
(The Wall Street Journal)
Mar-08-24 05:00AM
Feb-26-24 02:19PM
09:58AM
07:00AM
Feb-23-24 08:15PM
Feb-20-24 08:30AM
04:43AM
04:00AM
Feb-16-24 09:04AM
08:57AM
(Thomson Reuters StreetEvents)
Feb-13-24 12:08AM
Feb-12-24 10:18AM
(Yahoo Finance Video) +7.49%
Feb-09-24 05:02PM
Feb-05-24 09:02AM
Feb-01-24 11:42AM
Jan-31-24 04:05PM
(Investor's Business Daily)
03:51PM
02:55PM
01:30PM
01:07PM
10:30AM
10:20AM
09:09AM
(Investor's Business Daily)
08:10AM
07:52AM
07:20AM
07:00AM
06:32AM
06:20AM
06:00AM
Jan-28-24 12:42PM
Jan-26-24 09:15AM
Jan-25-24 09:40AM
Jan-23-24 01:43AM
Jan-12-24 09:00AM
(Investor's Business Daily)
Jan-10-24 05:21AM
Jan-02-24 04:30PM
Dec-29-23 06:43PM
06:34PM
06:14PM
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Weiss Amir Chief Accounting Officer May 16 '24 Sale 16.65 12,635 210,377 5,179 May 17 07:41 AM Weiss Amir Chief Accounting Officer May 15 '24 Sale 16.80 15,500 260,417 17,814 May 17 07:41 AM Conway Vikki L See "Remarks" May 13 '24 Sale 16.74 15,219 254,807 0 May 15 08:36 AM Kalif Eliyahu Sharon EVP, Chief Financial Officer Mar 06 '24 Sale 13.52 77,550 1,048,119 203,691 Mar 07 04:27 PM Sabag Mark EVP, International Markets Mar 05 '24 Sale 13.52 100,000 1,352,090 382,590 Mar 07 04:12 PM Daniell Richard Exec. VP, European Commercial Mar 05 '24 Sale 13.52 48,629 657,240 69,770 Mar 07 04:20 PM Conway Vikki L See "Remarks" Mar 05 '24 Sale 13.52 1,427 19,286 15,219 Mar 07 04:16 PM Daniell Richard Exec. VP, European Commercial Mar 04 '24 Sale 13.34 95,762 1,277,207 69,770 Mar 05 04:21 PM Francis Richard D President and CEO Mar 04 '24 Sale 13.34 31,061 414,270 123,295 Mar 05 04:27 PM Hughes Eric A See "Remarks" Mar 04 '24 Sale 13.34 8,045 107,299 16,855 Mar 05 04:16 PM Conway Vikki L See "Remarks" Mar 04 '24 Sale 13.37 3,532 47,234 6,617 Mar 05 04:39 PM Daniell Richard Exec. VP, European Commercial Feb 28 '24 Sale 13.12 20,599 270,176 69,770 Mar 01 06:43 AM Drape Eric Executive VP Global Operations Feb 28 '24 Sale 13.12 9,815 128,734 9,701 Mar 01 06:45 AM Conway Vikki L See "Remarks" Feb 28 '24 Sale 13.12 1,366 17,916 2,928 Mar 01 06:40 AM Drape Eric Executive VP Global Operations Feb 16 '24 Sale 13.05 173,261 2,261,905 1 Feb 21 07:37 AM Francis Richard D President and CEO Feb 15 '24 Sale 13.15 74,530 980,174 87,125 Feb 20 07:42 AM Weiss Amir Chief Accounting Officer Feb 01 '24 Sale 12.37 31,766 392,955 10,676 Feb 05 07:49 AM Kalif Eliyahu Sharon EVP, Chief Financial Officer Aug 07 '23 Sale 9.73 35,125 341,889 99,162 Aug 09 04:02 PM Weiss Amir Chief Accounting Officer Aug 04 '23 Sale 9.92 1,981 19,658 42,442 Aug 07 04:15 PM Hughes Eric A See "Remarks" Aug 01 '23 Sale 8.30 52,742 437,690 0 Aug 03 07:09 AM
Index S&P 500
P/E 33.74
EPS (ttm) 3.15
Insider Own 0.17%
Shs Outstand 244.52M
Perf Week -0.86%
Market Cap 26.01B
Forward P/E 28.27
EPS next Y 3.76
Insider Trans -66.80%
Shs Float 244.10M
Perf Month 3.09%
Income 780.10M
PEG 3.62
EPS next Q 0.84
Inst Own 88.49%
Short Float 2.48%
Perf Quarter 8.81%
Sales 5.94B
P/S 4.38
EPS this Y 9.10%
Inst Trans -0.88%
Short Ratio 5.17
Perf Half Y 16.08%
Book/sh 16.77
P/B 6.34
EPS next Y 8.83%
ROA 9.27%
Short Interest 6.06M
Perf Year 12.24%
Cash/sh 1.43
P/C 74.39
EPS next 5Y 9.33%
ROE 20.08%
52W Range 82.25 - 108.68
Perf YTD 12.51%
Dividend Est. 1.13 (1.06%)
P/FCF 33.54
EPS past 5Y 6.12%
ROI 12.03%
52W High -2.11%
Beta 0.51
Dividend TTM 1.11 (1.05%)
Quick Ratio 0.82
Sales past 5Y 7.24%
Gross Margin 42.57%
52W Low 29.35%
ATR (14) 1.51
Dividend Ex-Date May 14, 2024
Current Ratio 1.33
EPS Y/Y TTM 87.64%
Oper. Margin 18.02%
RSI (14) 53.79
Volatility 1.11% 1.56%
Employees 5550
Debt/Eq 0.59
Sales Y/Y TTM 7.86%
Profit Margin 13.13%
Recom 2.67
Target Price 98.12
Option/Short Yes / Yes
LT Debt/Eq 0.58
EPS Q/Q 12.38%
Payout 35.72%
Rel Volume 0.71
Prev Close 106.68
Sales Surprise 0.64%
EPS Surprise 10.04%
Sales Q/Q 5.14%
Earnings May 02 BMO
Avg Volume 1.17M
Price 106.39
SMA20 -0.21%
SMA50 1.61%
SMA200 9.63%
Trades
Volume 827,475
Change -0.27%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-01-24 Resumed
Goldman
Buy
$110
Feb-23-24 Upgrade
Argus
Hold → Buy
$115
Dec-15-23 Upgrade
BofA Securities
Underperform → Neutral
$85 → $100
Dec-13-23 Downgrade
Citigroup
Neutral → Sell
$90
Nov-13-23 Initiated
Jefferies
Hold
$99
Oct-23-23 Upgrade
Raymond James
Underperform → Mkt Perform
Sep-22-23 Initiated
HSBC Securities
Hold
$102
Aug-28-23 Upgrade
Truist
Hold → Buy
$95 → $105
Feb-17-23 Initiated
Citigroup
Neutral
$85
Feb-13-23 Downgrade
Argus
Buy → Hold
Feb-07-23 Reiterated
Oppenheimer
Outperform
$93
Feb-06-23 Upgrade
Atlantic Equities
Underweight → Neutral
$80
Jan-17-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$82 → $91
Jan-17-23 Upgrade
Credit Suisse
Neutral → Outperform
$85 → $95
Nov-07-22 Upgrade
Argus
Hold → Buy
$78
Oct-18-22 Initiated
Evercore ISI
In-line
Oct-17-22 Upgrade
Morgan Stanley
Underweight → Equal-Weight
$82
Oct-05-22 Upgrade
Deutsche Bank
Hold → Buy
$90 → $85
Sep-14-22 Resumed
BofA Securities
Underperform
$75
Sep-08-22 Downgrade
Truist
Buy → Hold
Show Previous Ratings
May-14-24 11:06AM
May-13-24 03:00PM
07:05AM
May-09-24 11:00AM
May-07-24 03:01PM
12:45PM
Loading…
12:45PM
11:11AM
May-06-24 01:38PM
May-03-24 11:29AM
11:07AM
10:56AM
10:54AM
10:41AM
09:29AM
08:59AM
08:43AM
Loading…
08:43AM
08:32AM
08:29AM
08:29AM
08:26AM
07:57AM
07:31AM
01:07AM
May-02-24 08:46PM
02:52PM
11:57AM
09:30AM
08:52AM
08:40AM
08:35AM
08:05AM
Loading…
08:05AM
07:45AM
07:05AM
07:04AM
(Associated Press Finance)
06:55AM
May-01-24 11:28AM
03:10AM
Apr-29-24 09:16AM
Apr-25-24 10:02AM
Apr-22-24 04:20PM
(Investor's Business Daily)
Apr-21-24 07:22AM
Apr-17-24 03:35PM
(Investor's Business Daily)
Apr-16-24 12:10PM
Apr-15-24 10:17AM
07:43AM
Apr-11-24 11:45AM
Apr-04-24 04:43AM
Apr-02-24 04:28AM
Mar-29-24 07:45AM
Mar-28-24 05:09AM
Mar-24-24 07:30PM
Mar-18-24 12:49PM
08:54AM
Mar-15-24 05:07PM
Mar-13-24 07:00AM
Mar-12-24 08:40AM
Mar-04-24 01:00AM
Feb-28-24 04:41AM
Feb-27-24 12:00PM
Feb-16-24 12:12AM
Feb-15-24 03:21PM
Feb-12-24 01:02PM
09:40AM
Feb-06-24 01:02PM
02:01AM
02:01AM
Feb-05-24 02:01AM
Feb-03-24 09:02AM
Feb-02-24 02:56PM
01:00PM
09:30AM
08:05AM
07:56AM
07:41AM
07:11AM
(Associated Press Finance)
07:08AM
06:55AM
Feb-01-24 02:00AM
Jan-30-24 11:20PM
09:03PM
10:29AM
09:15AM
Jan-26-24 10:34AM
10:00AM
Jan-25-24 03:49AM
Jan-24-24 08:45AM
Jan-19-24 12:10PM
Jan-16-24 04:35PM
Dec-20-23 07:42AM
Dec-14-23 04:51PM
Dec-07-23 09:08AM
07:24AM
Dec-01-23 04:40PM
Nov-22-23 12:12PM
Nov-16-23 07:07AM
Nov-14-23 05:07AM
Nov-07-23 12:43PM
Nov-05-23 02:23PM
Nov-04-23 01:34AM
(Thomson Reuters StreetEvents)
Nov-03-23 05:12PM
Church & Dwight Co., Inc. engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements. The Consumer International segment sells personal care products, household and over-the-counter products in Canada, France, Australia, China, the United Kingdom, Mexico, and Brazil. The Specialty Products segment consists of sales to businesses which participated in different product areas, namely animal productivity, specialty chemicals, and specialty cleaners. The Corporate segment includes equity in earnings of affiliates from Armand and ArmaKleen in 2021, 2020 and 2019. The company was founded by Dwight John and Austin Church in 1846 and is headquartered in Ewing, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SHEARER ROBERT K Director May 08 '24 Option Exercise 50.28 13,200 663,696 42,308 May 09 08:48 AM SHEARER ROBERT K Director May 08 '24 Sale 106.36 13,200 1,403,990 29,108 May 09 08:48 AM Price Penry W Director May 06 '24 Option Exercise 34.81 7,752 269,847 33,444 May 07 11:07 AM Price Penry W Director May 06 '24 Sale 105.47 7,752 817,608 25,692 May 07 11:07 AM Bruno Barry A. EVP, Chf Mktng Offcr Pres CD Mar 13 '24 Option Exercise 49.62 9,926 492,528 14,245 Mar 14 09:24 AM Bruno Barry A. EVP, Chf Mktng Offcr Pres CD Mar 13 '24 Sale 104.55 9,926 1,037,805 4,319 Mar 14 09:24 AM FARRELL MATTHEW President and CEO Mar 11 '24 Option Exercise 41.76 275,000 11,482,625 387,719 Mar 12 11:30 AM IRWIN BRADLEY C Director Mar 11 '24 Option Exercise 53.75 5,590 300,462 42,759 Mar 12 11:13 AM Read Michael EVP, International Mar 11 '24 Option Exercise 51.67 4,500 232,515 4,500 Mar 12 11:00 AM FARRELL MATTHEW President and CEO Mar 11 '24 Sale 103.83 275,000 28,552,535 112,719 Mar 12 11:30 AM IRWIN BRADLEY C Director Mar 11 '24 Sale 104.12 5,590 582,014 37,169 Mar 12 11:13 AM Read Michael EVP, International Mar 11 '24 Sale 105.00 4,500 472,500 0 Mar 12 11:00 AM Dierker Richard A EVP, CFO & Head of Business Op Mar 07 '24 Option Exercise 73.87 24,380 1,800,951 32,014 Mar 08 10:52 AM Dierker Richard A EVP, CFO & Head of Business Op Mar 07 '24 Sale 103.61 24,380 2,526,061 7,634 Mar 08 10:52 AM Saligram Ravichandra Krishnamu Director Mar 06 '24 Option Exercise 34.81 15,504 539,694 49,297 Mar 07 10:22 AM Buchert Brian D EVP of Strategy, M&A, and BP Mar 06 '24 Option Exercise 38.33 12,120 464,527 6,120 Mar 07 09:51 AM Saligram Ravichandra Krishnamu Director Mar 06 '24 Sale 102.25 15,504 1,585,315 33,793 Mar 07 10:22 AM Buchert Brian D EVP of Strategy, M&A, and BP Mar 06 '24 Sale 102.84 12,120 1,246,369 0 Mar 07 09:51 AM DE MAYNADIER PATRICK D EVP, Gen. Counsel & Secretary Mar 05 '24 Option Exercise 53.75 48,537 2,608,875 58,862 Mar 06 11:09 AM DE MAYNADIER PATRICK D EVP, Gen. Counsel & Secretary Mar 05 '24 Sale 102.00 48,537 4,950,796 10,325 Mar 06 11:09 AM Read Michael EVP, International Mar 04 '24 Option Exercise 51.67 9,000 465,030 9,000 Mar 05 01:29 PM Read Michael EVP, International Mar 04 '24 Sale 100.95 9,000 908,577 0 Mar 05 01:29 PM Bruno Barry A. EVP, Chf Mktng Offcr, Pres CD Feb 27 '24 Option Exercise 41.91 10,993 460,772 15,312 Feb 29 04:10 PM Bruno Barry A. EVP, Chf Mktng Offcr, Pres CD Feb 27 '24 Sale 99.66 10,993 1,095,519 4,319 Feb 29 04:10 PM Price Penry W Director Feb 09 '24 Option Exercise 34.81 7,752 269,847 33,444 Feb 12 11:45 AM Price Penry W Director Feb 09 '24 Sale 98.29 7,752 761,952 25,692 Feb 12 11:45 AM Hemsey Rene EVP, Chief HR Officer Feb 07 '24 Option Exercise 34.82 9,280 323,137 11,653 Feb 08 10:42 AM Hemsey Rene EVP, Chief HR Officer Feb 07 '24 Sale 100.22 9,280 930,025 6,373 Feb 08 10:42 AM FARRELL MATTHEW President and CEO Feb 06 '24 Option Exercise 41.76 275,000 11,482,625 387,719 Feb 07 02:28 PM Linares Carlos G. EVP Chief Tech&Global New Prod Feb 06 '24 Option Exercise 53.47 79,603 4,256,616 42,813 Feb 07 03:20 PM FARRELL MATTHEW President and CEO Feb 06 '24 Sale 100.28 275,000 27,578,182 112,719 Feb 07 02:28 PM Linares Carlos G. EVP Chief Tech&Global New Prod Feb 06 '24 Sale 100.59 79,603 8,007,656 2,730 Feb 07 03:20 PM WINKLEBLACK ARTHUR B Director Feb 05 '24 Option Exercise 49.62 12,960 643,075 20,089 Feb 06 10:31 AM IRWIN BRADLEY C Director Feb 05 '24 Option Exercise 51.88 10,960 568,615 42,367 Feb 06 10:52 AM WINKLEBLACK ARTHUR B Director Feb 05 '24 Sale 99.30 12,960 1,286,902 7,129 Feb 06 10:31 AM IRWIN BRADLEY C Director Feb 05 '24 Sale 99.35 10,960 1,088,864 36,367 Feb 06 10:52 AM Read Michael EVP, International Nov 30 '23 Option Exercise 51.67 4,500 232,515 4,500 Dec 01 10:11 AM Read Michael EVP, International Nov 30 '23 Sale 96.00 4,500 432,000 0 Dec 01 10:11 AM FARRELL MATTHEW President and CEO Aug 30 '23 Option Exercise 41.91 132,881 5,569,707 245,325 Aug 31 09:55 AM FARRELL MATTHEW President and CEO Aug 30 '23 Sale 96.00 132,881 12,756,576 112,444 Aug 31 09:55 AM FARRELL MATTHEW President and CEO Aug 14 '23 Option Exercise 41.91 27,181 1,139,292 139,625 Aug 15 01:39 PM FARRELL MATTHEW President and CEO Aug 14 '23 Sale 96.03 27,181 2,610,325 112,444 Aug 15 01:39 PM Dierker Richard A EVP, CFO & Head of Business Op Aug 10 '23 Option Exercise 73.87 90,000 6,648,300 97,544 Aug 14 01:00 PM FARRELL MATTHEW President and CEO Aug 10 '23 Option Exercise 41.91 1,280 53,651 113,724 Aug 14 01:17 PM Dierker Richard A EVP, CFO & Head of Business Op Aug 10 '23 Sale 95.80 90,000 8,622,369 7,544 Aug 14 01:00 PM FARRELL MATTHEW President and CEO Aug 10 '23 Sale 97.07 1,280 124,247 112,444 Aug 14 01:17 PM FARRELL MATTHEW President and CEO Aug 03 '23 Option Exercise 41.91 4,591 192,432 117,035 Aug 04 01:57 PM FARRELL MATTHEW President and CEO Aug 03 '23 Sale 97.07 4,591 445,666 112,444 Aug 04 01:57 PM FARRELL MATTHEW President and CEO Aug 02 '23 Option Exercise 37.82 7,006 264,959 116,483 Aug 03 11:08 AM FARRELL MATTHEW President and CEO Aug 02 '23 Sale 97.15 7,006 680,664 112,444 Aug 03 11:08 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite